Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ALB Stock Forecast 2026-2027
$120.78
Current Price
$14.24B
Market Cap
Buy 13
Hold 9
Sell 0
Wall St Analyst Ratings
Distance to ALB Price Targets
+115.3%
To High Target of $260.00
+62.3%
To Median Target of $196.00
-31.0%
To Low Target of $83.28
ALB Price Momentum
-4.2%
1 Week Change
-24.7%
1 Month Change
+56.7%
1 Year Change
-14.6%
Year-to-Date Change
-45.3%
From 52W High of $221.00
+86.0%
From 52W Low of $64.95
📊 TOP ANALYST CALLS
Did ALB Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Albemarle is one of their latest high-conviction picks.
Latest ALB Stock Price Targets & Analyst Predictions
Based on our analysis of 3 Wall Street analysts, ALB has a bullish consensus with a median price target of $196.00 (ranging from $83.28 to $260.00). The overall analyst rating is Strong Buy (8.1/10). Currently trading at $120.78, the median forecast implies a 62.3% upside. This outlook is supported by 13 Buy, 9 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ALB Analyst Ratings
13
Buy
9
Hold
0
Sell
ALB Price Target Range
Low
$83.28
Average
$196.00
High
$260.00
Current: $120.78
Latest ALB Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ALB.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jul 1, 2026 | Mizuho | John Roberts | Neutral | Maintains | $185.00 |
| Jun 18, 2026 | Citigroup | Buy | Upgrade | $N/A | |
| May 26, 2026 | RBC Capital | Outperform | Maintains | $N/A | |
| May 14, 2026 | Scotiabank | Sector Outperform | Maintains | $N/A | |
| May 11, 2026 | Argus Research | Buy | Maintains | $N/A | |
| May 11, 2026 | RBC Capital | Outperform | Maintains | $N/A | |
| May 8, 2026 | UBS | Buy | Maintains | $N/A | |
| May 8, 2026 | Citigroup | Neutral | Maintains | $N/A | |
| May 8, 2026 | Truist Securities | Buy | Maintains | $N/A | |
| May 8, 2026 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| May 7, 2026 | Mizuho | Neutral | Maintains | $N/A | |
| Apr 24, 2026 | RBC Capital | Outperform | Maintains | $N/A | |
| Apr 22, 2026 | Truist Securities | Buy | Maintains | $N/A | |
| Apr 21, 2026 | Citigroup | Neutral | Maintains | $N/A | |
| Apr 21, 2026 | B of A Securities | Buy | Maintains | $N/A | |
| Apr 17, 2026 | Baird | Neutral | Downgrade | $N/A | |
| Apr 9, 2026 | UBS | Buy | Maintains | $N/A | |
| Feb 18, 2026 | Evercore ISI Group | In-Line | Maintains | $N/A | |
| Feb 17, 2026 | RBC Capital | Outperform | Maintains | $N/A | |
| Feb 17, 2026 | B of A Securities | Buy | Upgrade | $N/A |
Albemarle Corporation (ALB) Competitors
The following stocks are similar to Albemarle based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Albemarle Corporation (ALB) Financial Data
Albemarle Corporation has a market capitalization of $14.24B with a P/E ratio of 33.5x. The company generates $5.49B in trailing twelve-month revenue with a -4.2% profit margin.
Revenue growth is +32.7% quarter-over-quarter, while maintaining an operating margin of +24.8% and return on equity of -1.8%.
Valuation Metrics
Market Cap
$14.24B
Enterprise Value
$17.65B
P/E Ratio
33.5x
PEG Ratio
0.0x
Price/Sales
2.6x
Growth & Margins
Revenue Growth (YoY)
+32.7%
Gross Margin
+35.1%
Operating Margin
+24.8%
Net Margin
-4.2%
EPS Growth
+671.7%
Financial Health
Cash/Price Ratio
+7.7%
Current Ratio
2.1x
Debt/Equity
19.8x
ROE
-1.8%
ROA
+1.6%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Albemarle Corporation (ALB) Business Model
About Albemarle Corporation
What They Do
Produces specialty chemicals for various industries.
Business Model
Albemarle Corporation generates revenue by producing and selling specialty chemicals, including lithium compounds, bromine-based solutions, and refining catalysts. Its business model is centered around three main segments: energy storage, specialties, and ketjen, allowing the company to provide critical inputs to various sectors such as electric vehicles, pharmaceuticals, and oil and gas.
Additional Information
Headquartered in Charlotte, North Carolina, Albemarle is recognized for its diversified portfolio and strong market position in high-performance chemical solutions, catering to essential industries that depend on advanced manufacturing processes.
Company Information
Sector
Basic Materials
Industry
Specialty Chemicals
Employees
7,800
CEO
Mr. Jerry Kent Masters Jr.
Country
United States
IPO Year
1994
Website
www.albemarle.comAlbemarle Corporation (ALB) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Albemarle (ALB) Rises As Market Takes a Dip: Key Facts
Albemarle (ALB) closed at $120.78 in the latest trading session, marking a +1.1% move from the prior day.
Jul 17, 2026
By Zacks Equity Research
Tale of the Tape
NGVT's Evotherm P35 Gets German Approval for Warm-Mix Asphalt Use
Ingevity's Evotherm P35 earns German approval after rigorous testing, clearing it for use in warm-mix asphalt for federal projects.
Jul 17, 2026
By Zacks Equity Research
Analyst Blog
Albemarle (ALB) Registers a Bigger Fall Than the Market: Important Facts to Note
In the closing of the recent trading day, Albemarle (ALB) stood at $119.46, denoting a -4.23% move from the preceding trading day.
Jul 16, 2026
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
Zacks Style Scores can assist investors in selecting strong, market-beating stocks for their portfolios.
Why It Matters
Zacks Style Scores can help identify stocks with strong potential for outperformance, guiding investment decisions and enhancing portfolio returns.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Albemarle's stock has dropped 25% due to lower lithium prices; however, strong demand, productivity improvements, and increasing earnings estimates may positively impact future performance.
Why It Matters
Albemarle's stock drop signals market concerns over lithium prices, but strong demand and improved earnings could indicate a potential recovery, influencing investment decisions.
Source: Zacks Investment Research
Market Sentiment:
Negative
Albemarle Corporation (ALB) is Attracting Investor Attention: Here is What You Should Know
3 days ago
Quick Summary
Albemarle (ALB) is currently attracting significant attention from Zacks.com users, indicating potential interest and future developments for the stock.
Why It Matters
Increased attention on Albemarle (ALB) suggests potential volatility or opportunity, prompting investors to reassess their positions based on market sentiment and future performance expectations.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
SK Hynix's successful ADR debut enhances tech sector optimism, while increasing geopolitical risks highlight five low-leverage stocks designed for resilience.
Why It Matters
SK Hynix's strong ADR debut signals tech sector strength, while rising geopolitical risks highlight the need for resilient, low-leverage stocks, influencing investment strategies.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Albemarle (ALB) closed at $126.05, down 1.85% from the previous trading session.
Why It Matters
Albemarle's decline of 1.85% signals potential volatility, impacting investor sentiment and indicating shifts in market perception that could affect future performance.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Quick Summary
Rare-earth metals, comprising 17 elements with unique properties, are crucial for modern technology, making them a significant long-term investment opportunity.
Why It Matters
Rare-earth metals are crucial for tech advancements, influencing demand and pricing. Their scarcity and essential use in industries can drive investment growth and portfolio diversification.
Source: MarketBeat
Market Sentiment:
Positive
Frequently Asked Questions About ALB Stock
What is Albemarle Corporation's (ALB) stock forecast for 2027?
Based on our analysis of 3 Wall Street analysts, Albemarle Corporation (ALB) has a median price target of $196.00. The highest price target is $260.00 and the lowest is $83.28.
Is ALB stock a good investment in 2027?
According to current analyst ratings, ALB has 13 Buy ratings, 9 Hold ratings, and 0 Sell ratings. The stock is currently trading at $120.78. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ALB stock?
Wall Street analysts predict ALB stock could reach $196.00 in the next 12 months. This represents a 62.3% increase from the current price of $120.78. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Albemarle Corporation's business model?
Albemarle Corporation generates revenue by producing and selling specialty chemicals, including lithium compounds, bromine-based solutions, and refining catalysts. Its business model is centered around three main segments: energy storage, specialties, and ketjen, allowing the company to provide critical inputs to various sectors such as electric vehicles, pharmaceuticals, and oil and gas.
What is the highest forecasted price for ALB Albemarle Corporation?
The highest price target for ALB is $260.00 from at , which represents a 115.3% increase from the current price of $120.78.
What is the lowest forecasted price for ALB Albemarle Corporation?
The lowest price target for ALB is $83.28 from at , which represents a -31.0% decrease from the current price of $120.78.
What is the overall ALB consensus from analysts for Albemarle Corporation?
The overall analyst consensus for ALB is bullish. Out of 3 Wall Street analysts, 13 rate it as Buy, 9 as Hold, and 0 as Sell, with a median price target of $196.00.
How accurate are ALB stock price projections?
Stock price projections, including those for Albemarle Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 18, 2026 7:20 PM UTC